Investigating how lysosomes communicate with the nucleus in aging and Alzheimer's disease

Lysosome Regulation and Signaling in Aging and Alzheimer's Disease

NIH-funded research Baylor College of Medicine · NIH-11200904

This study is looking at how tiny cell structures called lysosomes communicate with the cell's control center, the nucleus, to keep our cells healthy as we age and in Alzheimer's disease, hoping to find ways to help clear out harmful proteins and improve health for those affected by these conditions.

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionBaylor College of Medicine NIH-funded
Lab location1 site (Houston, United States)
Project IDNIH-11200904 on NIH RePORTER

What this research studies

This research focuses on understanding the signaling pathways between lysosomes and the nucleus that regulate cellular health in aging and Alzheimer's disease. By using advanced imaging techniques and mouse models, the team aims to explore how lysosomal function impacts cellular clearance mechanisms, particularly in conditions related to tau protein accumulation. The research involves in vitro culture systems and requires specialized equipment to visualize these processes effectively. Patients may benefit from insights gained into how to enhance cellular clearance and potentially improve outcomes in Alzheimer's disease.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals experiencing symptoms of Alzheimer's disease or those at risk due to aging.

Not a fit: Patients with non-neurodegenerative conditions or those not affected by Alzheimer's disease may not receive any benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for enhancing cellular health and clearance mechanisms in patients with Alzheimer's disease.

How similar studies have performed: Other research has shown promising results in understanding lysosomal function in neurodegenerative diseases, indicating that this approach has potential for significant breakthroughs.

Where this research is happening

Houston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.